1,718
Views
0
CrossRef citations to date
0
Altmetric
Original Articles: Clinical Onology

Risk of second HPV-associated cancers in men with penile cancer

, , , , , , & show all
Pages 667-671 | Received 03 Sep 2020, Accepted 29 Jan 2021, Published online: 22 Apr 2021

References

  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
  • Kirrander P, Sherif A, Friedrich B, et al.; Steering Committee of the Swedish National Penile Cancer Register. Swedish National Penile Cancer Register: incidence, tumour characteristics, management and survival. BJU Int. 2016;117(2):287–292. Feb
  • Calmon MF, Tasso Mota M, Vassallo J, et al. Penile carcinoma: risk factors and molecular alterations. ScientificWorldJournal. 2011;11:269–282.
  • Serrano B, Brotons M, Bosch FX, et al. Epidemiology and burden of HPV-related disease. Best Pract Res Clin Obstet Gynaecol. 2018;47:14–26.
  • Chaturvedi AK. Beyond cervical cancer: burden of other HPV-related cancers among men and women. J Adolesc Health. 2010;46(4 Suppl):S20–S6.
  • Kirrander P, Kolaric A, Helenius G, et al. Human papillomavirus prevalence, distribution and correlation to histopathological parameters in a large Swedish cohort of men with penile carcinoma. BJU Int. 2011;108(3):355–359.
  • Tanaka TI, Alawi F. Human papillomavirus and oropharyngeal cancer. Dent Clin North Am. 2018;62(1):111–120.
  • Bansal A, Singh MP, Rai B. Human papillomavirus-associated cancers: A growing global problem. Int J Appl Basic Med Res. 2016;6(2):84–89.
  • Arbyn M, de Sanjose S, Saraiya M, et al. EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease. Int J Cancer. 2012;131(9):1969–1982.
  • de Martel C, Plummer M, Vignat J, et al. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664–670.
  • Olesen TB, Sand FL, Rasmussen CL, et al. Prevalence of human papillomavirus DNA and p16(INK4a) in penile cancer and penile intraepithelial neoplasia: a systematic review and meta-analysis. Lancet Oncol. 2019;20(1):145–158.
  • Tumban E. A Current Update on Human Papillomavirus-Associated Head and Neck Cancers. Viruses. 2019;11(10):922.
  • De Vuyst H, Clifford GM, Nascimento MC, et al. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer. 2009;124(7):1626–1636.
  • Suk R, Mahale P, Sonawane K, et al. Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers. JAMA Netw Open. 2018;1(5):e181999
  • Nelson RA, Lai LL. Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer. Cancer. 2017;123(20):4013–4021.
  • Neumann F, Jegu J, Mougin C, et al. Risk of second primary cancer after a first potentially-human papillomavirus-related cancer: A population-based study. Prev Med. 2016;90:52–58.
  • Saleem AM, Paulus JK, Shapter AP, et al. Risk of anal cancer in a cohort with human papillomavirus-related gynecologic neoplasm. Obstet Gynecol. 2011;117(3):643–649.
  • Balamurugan A, Ahmed F, Saraiya M, et al. Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors. Cancer. 2008;113(10 Suppl):2919–2925.
  • Valari O, Koliopoulos G, Karakitsos P, et al. Human papillomavirus DNA and mRNA positivity of the anal canal in women with lower genital tract HPV lesions: predictors and clinical implications. Gynecol Oncol. 2011;122(3):505–508.
  • Razzaghi H, Saraiya M, Thompson TD, et al. Five-year relative survival for human papillomavirus-associated cancer sites. Cancer. 2018;124(1):203–211.
  • Daling JR, Madeleine MM, Johnson LG, et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer. 2004;101(2):270–280.
  • The Swedish National Board of Health and Welfare. The Swedish Cancer Register 2019 [April 5, 2020]. Available from: https://www.socialstyrelsen.se/en/statistics-and-data/registers/register-information/swedish-cancer-register/.
  • Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
  • Breslow NE, Day NE. Statistical methods in cancer research. Volume II–The design and analysis of cohort studies. IARC Sci Publ. 1987;(82):1–406.
  • von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. [Internet]. 2020. Available from: https://www.goodreports.org/strobe-cohort/.
  • Gilbert DC, Wakeham K, Langley RE, et al. Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis. Br J Cancer. 2019;120(2):256–268.
  • Lei J, Ploner A, Elfstrom KM, et al. HPV Vaccination and the Risk of Invasive Cervical Cancer. N Engl J Med. 2020;383(14):1340–1348.
  • Swedish KA, Factor SH, Goldstone SE. Prevention of recurrent high-grade anal neoplasia with quadrivalent human papillomavirus vaccination of men who have sex with men: a nonconcurrent cohort study. Clin Infect Dis. 2012;54(7):891–898.
  • Valvo F, Ciurlia E, Avuzzi B, et al. Cancer of the anal region. Crit Rev Oncol Hematol. 2019;135:115–127.